1. Introduction
===============

Plants of genus *Daphniphyllum* are mainly distributed in southeast of Asia and are well known for producing highly polycyclic and structurally diverse alkaloids, which have drawn a great deal of attention from the biogenetic and synthetic points of view \[[@B1-molecules-19-03055],[@B2-molecules-19-03055],[@B3-molecules-19-03055],[@B4-molecules-19-03055]\]. In recent years, a great number of *Daphniphyllum* alkaloids have been isolated and identified, and some of them exhibited significant cytotoxic activity against several human cancer cell lines \[[@B5-molecules-19-03055],[@B6-molecules-19-03055],[@B7-molecules-19-03055],[@B8-molecules-19-03055],[@B9-molecules-19-03055],[@B10-molecules-19-03055],[@B11-molecules-19-03055],[@B12-molecules-19-03055],[@B13-molecules-19-03055],[@B14-molecules-19-03055],[@B15-molecules-19-03055],[@B16-molecules-19-03055],[@B17-molecules-19-03055],[@B18-molecules-19-03055],[@B19-molecules-19-03055]\].

In the past years, a series of new bioactive compounds have been studied in our laboratory \[[@B20-molecules-19-03055],[@B21-molecules-19-03055],[@B22-molecules-19-03055],[@B23-molecules-19-03055],[@B24-molecules-19-03055]\]. With the purpose of searching for bioactive and structurally unique *Daphniphyllum* alkaloids, an investigation of the extracts from the stem bark of *Daphniphyllum macropudum* was conducted, and this resulted in the isolation of five new alkaloids named daphnicyclidins M and N (compounds **1** and **2**) and calyciphyllines Q--S (compounds **3**--**5**), and four known related alkaloids **6**--**9** ([Figure 1](#molecules-19-03055-f001){ref-type="fig"}). More than 20 alkaloids have been isolated from the stem bark of *D. macropudum* and identified, including various structure types such as yuzurimine-type, daphnicyclidin-type, daphnezomine-type, calyciphylline-type, daphmanidin-type and daphniglaucin-type \[[@B25-molecules-19-03055],[@B26-molecules-19-03055],[@B27-molecules-19-03055],[@B28-molecules-19-03055]\]. Compounds **1** and **2** are daphnicyclidin-type alkaloids, and **3**--**5** are calyciphylline-type alkaloids. The analog which shares a similar gross structure with daphnicyclidins M and N has been isolated for only once by Kobayashi \[[@B29-molecules-19-03055]\]. Calyciphylline Q (**3**) is the first calyciphylline A derivative possessing a double bond between C-18 and C-19. This paper presents the isolation and structural elucidation of the new compounds **1**--**5**, along with their cytotoxic activities against four tumor cell lines, P-388 (mouse lymphocytic leukemia), A-549 (human lung carcinoma), SGC-7901 (human gastric carcinoma) and HL-60 (human promyelocytic leukemia).

![Structures of compounds **1**--**9**.](molecules-19-03055-g001){#molecules-19-03055-f001}

2. Results and Discussion
=========================

Daphnicyclidin M (**1**) was obtained as light yellow powder. The molecular formula was determined as C~23~H~25~NO~5~ by HREIMS at *m/z* 418.1632 (\[M+Na\]^+^, calcd for C~23~H~25~NO~5~Na, 418.1630), which indicated 12 degrees of unsaturation. ^13^C-NMR ([Table 1](#molecules-19-03055-t001){ref-type="table"}) and DEPT spectra revealed 23 carbon signals due to three tetrasubstituted olefins, one disubstituted olefin, two carbonyls, two sp^3^ quaternary carbons, three sp^3^ methines, five sp^3^ methylenes, two sp^3^ methyls and one methoxy group. Among them, two methylenes (δ~C~ = 60.1, δ~H~ = 2.37 and 3.07; δ~C~ = 53.1, δ~H~ = 2.63 and 3.06) and one methine (δ~C~ = 67.9, δ~H~ = 3.50) were ascribed to those bearing a nitrogen, while two olefin carbons (δ~C~ = 168.4 and δ~C~ = 146.1, δ~H~ = 7.93) and one sp^3^ quaternary carbon (δ~C~ = 77.8) were assigned to those bearing oxygen atoms. Since six out of 12 degrees of unsaturation were accounted for, **1** was inferred to possess six rings.

molecules-19-03055-t001_Table 1

###### 

^1^H-NMR (500 MHz) and ^13^C-NMR (125 MHz) data for compounds **1**--**5** (δ in ppm, *J* in Hz).

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------
  C       1 ^a^   2 ^a^               3 ^a^   4 ^a^                   5 ^b^                                                                   
  ------- ------- ------------------- ------- ----------------------- ------- ----------------------- ------- ----------------------- ------- -------------------
  1       77.8    \-                  78.9    \-                      209.2   \-                      217.6   \-                      216.4   \-

  2       213.1   \-                  212.4   \-                      44.4    2.93 (t, 3.1)           43.3    2.38 (brd, 5.0)         41.5    2.28--2.31 (m)

  3a\     31.4    2.26 (d, 3.4)\      33.9    2.18 (d, 14.8)\         24.4    1.97 (dt, 14.1, 2.7)\   34.6    1.86--1.92 (m)\         18.6    2.38--2.40 (m)\
  3b              2.26 (d, 3.4)               2.35 (d, 14.8)                  2.26 (dt, 14.2, 3.1)            2.76--2.78 (m)                  2.64--2.66 (m)

  4       67.9    3.50 (t, 3.3)       98.0    \-                      64.6    3.07--3.09 (m)          90.4    4.00 (t, 2.2)           87.9    3.93 (br s)

  5       46.8    \-                  53.3    \-                      55.9    \-                      54.7    \-                      52.5    \-

  6       46.7    2.56--2.58 (m)      42.3    2.85--2.88 (m)          58.0    1.78--1.85 (m)          47.2    3.01--3.07 ^c^          45.2    2.89 (t, 7.6)

  7a\     60.1    2.37 (t, 9.6)\      59.4    2.31 (dd, 8.2, 2.8)\    61.9    2.92 (d, 9.4)\          69.6    3.12 (t, 6.3)\          67.4    3.04--3.09 (m)\
  7b              3.06--3.08 (m)              3.13--3.16 (m)                  3.28--3.31 (m)                  3.51 (t, 13.2)                  3.26--3.32 (m)

  8       126.7   \-                  128.5   \-                      57.3    \-                      72.3    \-                      69.7    \-

  9       108.8   \-                  108.2   \-                      150.7   \-                      139.7   \-                      136.9   \-

  10      168.4   \-                  168.1   \-                      151.7   \-                      206.1   \-                      202.8   \-

  11a\    31.0    2.98--3.01 (m)\     31.1    2.94--2.98 (m)\         34.5    2.06--2.14 (m)\         37.2    2.32--2.35 (m)\         36.0    2.12--2.15 (m)\
  11b             3.67--3.73 (m)              3.65--3.69 (m)                  2.36 (d, 18.5)                  2.32--2.35 (m)                  2.12--2.15 (m)

  12a\    28.2    1.69--1.73 (m)\     27.6    1.67--1.75 (m)\         32.1    1.32--1.37 (m)\         19.4    1.86--1.92 (m)\         17.8    1.71--1.74 (m)\
  12b             2.57--2.59 (m)              2.54--2.58 (m)                  1.78--1.85 (m)                  2.01--2.08 (m)                  1.91--1.98 (m)

  13a\    142.0   \-\                 141.5   \-\                     47.6    2.81 (d, 16.5)\         20.2    2.44--2.50 (m)\         32.9    1.68--1.71 (m)\
  13b             -                           -                               3.40 (d, 17.7)                  2.78--2.82 (m)                  2.62--2.65 (m)

  14a\    123.2   \-\                 123.3   \-\                     115.9   \-\                     33.2    2.64 (t, 8.7)\          35.9    2.32--2.37 (m)\
  14b             -                           -                               -                               2.74--2.77 (m)                  2.50--2.52 (m)

  15      134.4   \-                  134.7   \-                      173.5   \-                      154.6   \-                      156.4   \-

  16a\    111.8   7.70 (d, 5.3)\      117.7   7.69 (d, 5.3)\          26.8    2.74--2.78 (m)\         132.5   6.89 (dd, 10.8, 6.7)\   33.3    2.18--2.23 (m)\
  16b             -                           -                               2.74--2.74 (m)                  -                               2.66--2.70 (m)

  17a\    146.1   7.93 (d, 5.3)\      145.9   7.92 (d, 5.3)\          41.7    2.78--2.80 (m)\         122.2   5.42 (d, 10.8)\         59.1    3.43--3.45 (m)\
  17b             -                           -                               2.85--2.87 (m)                  5.52 (d, 17.5)                  3.50--3.53 (m)

  18      36.9    2.66--2.70 (m)      39.1    2.49--2.53(m)           112.8   \-                      33.0    2.57--2.62(m)           31.0    2.43--2.47 (m)

  19a\    53.1    2.61--2.65 (m)\     53.8    2.91 (dd, 15.6, 2.8)\   135.8   5.77(s)\                68.2    3.01--3.07 ^c^\         66.1    2.99--3.04 (m)\
  19b             3.02--3.06 (m)              3.17 (dd, 15.2, 2.3)            -                               3.63 (dd, 13.3, 7.1)            3.55--3.57 (m)

  20      14.0    0.81 (3H, d, 6.7)   13.3    0.83 (3H, d, 6.7)       19.9    1.70 (3H, s)            19.6    1.14 (3H, d, 6.7)       18.9    1.03 (3H, d, 6.7)

  21      28.8    1.48 (3H, s)        25.6    1.46 (3H, s)            27.2    1.20 (3H, s)            23.2    1.50 (3H, s)            22.1    1.39 (3H, s)

  22      169.0   \-                  169.0   \-                      168.1   \-                      \-      \-                      \-      \-

  23      51.9    3.83 (3H, s)        51.8    3.82 (3H, s)            51.8    3.70 (3H, s)            \-      \-                      \-      \-

  4-OMe   \-      \-                  50.0    3.35 (3H, s)            \-      \-                      \-      \-                      \-      \-
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------

^a^ Measured in CD~3~OD; ^b^ Measured in DMSO-*d~6~*; ^c^ Overlapped.

Four partial structures: **a** (C-18 to C-19 and C-20), **b** (C-3 to C-4), **c** (C-6 to C-7 and C-12, and C-11 to C-12) and **d** (C-16 to C-17) were deduced from the extensive analysis of the 2D NMR data of **1**, including HSQC, ^1^H-^1^H COSY and HMBC, as shown in [Figure 2](#molecules-19-03055-f002){ref-type="fig"}. The HMBC correlations from H~2~-3 to C-1, C-2 and C-13, and H-4 to C-1 indicated C-2, C-3 and C-13 were all connected to C-1; H-19b and H~3~-20 to C-2 suggested the connectivity between C-18 and C-2. HMBC correlations from H-7b to C-4, H-7a to C-19 and H-19a to C-4 and C-7 gave rise to the connectivity of partial structures **a**, **b** and **c** through a nitrogen atom. The connections between C-4, C-6 and C-8 to C-21 through C-5 were confirmed by the HMBC correlations from H~2~-3 and H-4 to C-5, H-4 and H-6 to C-8 and H~3~-21 to C-4, C-5, C-6 and C-8, and this constructed the ring C. HMBC correlations from H~2~-12 and H~2~-11 to C-10 and H-11b to C-9 implied that C-11 and C-9 were connected through C-10. The presence of ring F was elucidated by the chemical shifts of C-10 (δ~C~ = 168.4) and C-17 (δ~C~ = 146.1), and HMBC correlations of H-17 to C-10 and C-15, and H-16 to C-9. The ring E and the methoxy carbonyl group at C-14 were deduced from a comprehensive analysis of the chemical shifts \[126.7 (C-8), 108.8 (C-9), 168.4 (C-10), 142.0 (C-13), 123.2 (C-14), 134.4 (C-15)\] and HMBC correlation of H-16 to C-14, and H~3~-23 to C-22. The relative configuration of **1** was elucidated by NOESY correlations as depicted in a computer-generated three-dimensional drawing, as shown in [Figure 3](#molecules-19-03055-f003){ref-type="fig"}.

![Selected 2D NMR correlations of daphnicyclidin M (**1**).](molecules-19-03055-g002){#molecules-19-03055-f002}

![Key NOESY correlations of daphnicyclidin M (**1**).](molecules-19-03055-g003){#molecules-19-03055-f003}

The NOESY correlations of H~3~-21 to H-4 and H-4 to H-6 indicated that H-4 and H-6 were in the β-orientation. The α-orientation of H-18 was deduced from the NOESY correlations of H-18 to H-7a and H-7b to H-4. Thus, it was clear that the ring B took a boat conformation. In consideration of biosynthetic pathway \[[@B20-molecules-19-03055]\] and the boat conformation of ring B, the OH group at C-1 must be β-oriented. The NOESY correlations of H~3~-21 to H-11b implied that ring D took a twist-boat conformation, similar to that of daphnicyclidin A \[[@B30-molecules-19-03055]\]. Thus, the structure of daphnicyclidin M was assigned as **1**, which is the C-4 dehydroxylated, C-16 and C-17 dehydrogenated derivative of daphnicyclidin K \[[@B29-molecules-19-03055]\].

Daphnicyclidin N (**2**) showed a molecular formula of C~24~H~27~NO~6~, as determined by HREIMS at *m/z* 448.1738 (\[M+Na\]^+^, calcd. for C~24~H~27~NO~6~Na, 448.1736). The comparison of the ^1^H-NMR and ^13^C-NMR ([Table 1](#molecules-19-03055-t001){ref-type="table"}) data of **2** with those of **1** suggested that the two alkaloids shared the same gross structure. The main difference bteween the two alkaloids was the fact that the molecular weight of **2** was larger than that of **1** by 30 units. Thus, it was proposed that the H-4 was replaced by a methoxy group. This was proved by the chemical shift of C-4 (δ~C~ = 98.0) which was shifted downfield ∆δ~C~ = +30.1 as compared with that of **1**, and the HMBC cross-peak of the H~3~ signal (δ~H~ = 3.35, s) to C-4 (Supporting Information). The relative configuration of **2** was the same as that of **1**, thus, OH-1, H-6, CH~3~-20 and CH~3~-21 were also β-oriented. Because the chemical shift of C-21 (δ~C~ = 25.6) was shifted upfield (∆δ~C~ = −2.65) for the γ-steric compression effect from oxygen atom of C-4, the methoxy group at C-4 was also deduced as the β-orientation \[[@B31-molecules-19-03055]\].

Calyciphylline Q (**3**) was obtained as a light yellow oil, exhibiting a pseudomolecular ion peak at *m/z* 388 \[M+Na\]^+^ in the ESIMS. The molecular formula C~23~H~27~NO~3~ of **3** was established by HRESIMS at *m/z* 388.1890 (\[M+Na\]^+^, calcd. for C~23~H~27~NO~3~Na, 388.1889), corresponding to 11 degrees of unsaturation. The ^13^C-NMR ([Table 1](#molecules-19-03055-t001){ref-type="table"}) and DEPT spectra showed 23 carbon signals including two carbonyls, three double bonds, two sp^3^ quaternary carbons, three sp^3^ methines, seven sp^3^ methylenes, two sp^3^ methyls and one methoxy group. Among them one methylene (δ~C~ = 61.9, δ~H~ = 2.92 and 3.30), one methine (δ~C~ = 64.6, δ~H~ = 3.09) and one double bond carbon (δ~C~ = 135.8, δ~H~ = 5.77) were assigned to those bearing a nitrogen.

The ^1^H-^1^H COSY spectrum of **3** revealed the connectivities of three structure fragments **a** (C-2 to C-4), **b** (C-6 to C7 and C-12, and C-11 to C-12) and **c** (C-16 to C-17) as shown in [Figure 4](#molecules-19-03055-f004){ref-type="fig"}. The connection of C-4, C-7 and C-19 to each other through a nitrogen atom was deduced from the HMBC correlations from H-4 to C-19, H-7a to C-4, and H-7b to C-19 and H-19 to C-4. The ring B was elucidated by the HMBC correlations of H-2 to C-18, H-19 to C-2, C-18 and C-20, H~3~-20 to C-2, C-18 and C-19. A ketone carbonyl at C-1 was revealed from HMBC cross-peaks of H-2 and H-3a to C-1. The HMBC correlations from H~3~-21 to C-4, C-5 and C-6, from H-3a, H-7a and H-12a to C-5 indicated the connectivities of C-21 to C-4 and C-6 via C-5. The connectivity of fragment **b** and **c** through C-10 and the presence of ring F were suggested by the HMBC correlations from H-11a, H~2~-16 and H-17a to C-10, from H~2~-11 and H-17b to C-9, and from H~2~-16 and H-17a to C-15. The linkages of C-13 to C-1, C-5 and C-9 through C-8 were confirmed by the HMBC correlations of H~2~-13 to C-5, H~3~-21 to C-5 and C-8, and H-13a to C-1 and C-9. The ring E was elucidated on the basis of the HMBC correlations of H-13a to C-15, H~2~-16 to C-15 and C-14 and H-17a to C-15. The methoxycarbonyl group at C-14 was deduced from a comprehensive analysis of the chemical shifts \[150.7 (C-9), 151.7 (C-10), 115.9 (C-14), 173.5 (C-15)\] and HMBC correlation of H-13b to C-22, H~2~-16 to C-14, and H~3~-23 to C-22. The relative configuration of **3** was elucidated by NOESY spectrum as shown in [Figure 5](#molecules-19-03055-f005){ref-type="fig"}. The NOESY correlations of H~3~-21 to H-3b, H-4 and H-6 indicated that H-3b, H-4, H-6 and CH~3~-21 were all on the same side, and assumed to be in β-orientation just the same as those of daphniyunnine A \[[@B32-molecules-19-03055]\]. The β-orientation of H-2 was implied by the NOESY correlation of H-2 with H-13a. The correlation of H-13b to H~3~-21 suggested that C-13 was β-oriented. The boat conformation of ring D was deduced from the NOESY correlation of H~3~-21 to H-12a. Thus, the structure of calyciphylline Q was elucidated as **3**.

![Selected 2D NMR correlations of calyciphylline Q (**3**).](molecules-19-03055-g004){#molecules-19-03055-f004}

![Key NOESY correlations of calyciphylline Q (**3**).](molecules-19-03055-g005){#molecules-19-03055-f005}

Calyciphylline R (**4**) exhibited a pseudomolecular ion peak at *m/z* 342 \[M+H\]^+^ in the ESIMS, and the molecular formula was established as C~21~H~27~NO~3~ by HRESIMS at *m/z* 342.2068 (\[M+H\]^+^, calcd. for C~21~H~28~NO~3~, 342.2069), corresponding to nine degrees of unsaturation. The ^13^C-NMR ([Table 1](#molecules-19-03055-t001){ref-type="table"}) of **4** revealed 21 carbon resonances, which were classified into two carbonyls, two double bonds, two sp^3^ quaternary carbons, four sp^3^ methines, seven sp^3^ methylenes, and two methyl groups. One methine (δ~C~ = 90.4, δ~H~ = 4.00) and two methylenes (δ~C~ = 68.2, δ~H~ = 3.04 and 3.63; δ~C~ = 69.6, δ~H~ = 3.12 and 3.51) were ascribed to those bearing an oxidative nitrogen. Comparison of the NMR (^1^H-NMR, ^13^C-NMR, HSQC, ^1^H-^1^H COSY and HMBC) spectra of **4** with those of daphlongamine E \[[@B33-molecules-19-03055]\], suggested that the two compounds are closely related. However, significant downfield changes of the chemical shifts of C-4 (δ~C~ = 90.4), C-7 (δ~C~ = 69.6) and C-19 (δ~C~ = 68.2) in relation to those of daphlongamine E (C-4 (δ~C~ = 65.5), C-7 (δ~C~ = 53.6) and C-19 (δ~C~ = 49.8)) indicated that the former one is the N-oxide form of the latter one \[[@B34-molecules-19-03055]\]. Thus, the relative configuration of **4** is the same as daphlongamine E.

Calyciphylline S (**5**) showed a pseudomolecular ion peak at *m/z* 360 \[M+H\]^+^ in the ESIMS, and the molecular formula was determined as C~21~H~29~NO~4~ by HRESIMS at *m/z* 360.2172 (\[M+H\]^+^, calcd. for C~21~H~30~NO~4~, 360.2175), with 8 degrees of unsaturation. The ^13^C-NMR ([Table 1](#molecules-19-03055-t001){ref-type="table"}) and DEPT spectra of **5** revealed 21 carbon signals, ascribed to two carbonyls, one tetrasubstituted olefin, two sp^3^ quaternary carbons, four sp^3^ methines, nine sp^3^ methylenes and two sp^3^ methyl groups. Among them, one methine (δ~C~ = 87.9, δ~H~ =3.93) and two methylenes (δ~C~ = 66.1, δ~H~ = 3.04 and 3.56; δ~C~ = 67.4, δ~H~ = 3.10 and 3.30) were ascribed to those bearing an oxidative nitrogen. Since three out of eight degrees of unsaturation have been accounted for, **5** was inferred to possess five rings. A comparison of the ^13^C chemical shifts of C-4 (δ~C~ = 87.9), C-7 (δ~C~ = 67.4) and C-19 (δ~C~ = 66.1) in **5** with those of daphniyunnine B (longeracinphyllin B) indicated the presence of an N-oxide group attached to those C-atoms \[[@B32-molecules-19-03055],[@B35-molecules-19-03055]\]. Thus calyciphylline S was inferred to be the N-oxide form of daphniyunnine B (longeracinphyllin B), which was confirmed by the 2D NMR (HSQC, ^1^H-^1^H COSY and HMBC) spectra of **5** (Supporting Information). The structure of calyciphylline S (**5**) could also be deduced from the comparison of the ^1^H-NMR and ^13^C-NMR data ([Table 1](#molecules-19-03055-t001){ref-type="table"}) of **5** with those of **4**. It could be easily inferred that compound **5** was the water addition product of **4** at C-16 and C-17, since one methine (δ~C~ = 132.5, δ~H~ = 6.89) and one methylene (δ~C~ = 122.2, δ~H~ = 5.42 and 5.52) disappeared in compound **4** while two methylenes (δ~C~ = 33.3, δ~H~ = 2.22 and 2.68; δ~C~ = 59.1, δ~H~ = 3.44 and 3.51) emerged in **5**.

Four known alkaloids were identified as paxiphylline C \[[@B36-molecules-19-03055]\], macropodumine B \[[@B37-molecules-19-03055]\], macropodumine C \[[@B37-molecules-19-03055]\] and daphnicyclidin A \[[@B30-molecules-19-03055]\] on the basis of the comparison of their ^1^H-NMR, ^13^C-NMR and ESIMS data with that reported.

The cytotoxicity of the new compounds were evaluated against mouse lymphocytic leukemia P-388 cells, human lung carcinoma A-549 cells, human gastric carcinoma SGC-7901 cells and human promyelocytic leukemia HL-60 cells using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) colorimetric assay method *in vitro* \[[@B38-molecules-19-03055]\]. As shown in [Table 2](#molecules-19-03055-t002){ref-type="table"}, compounds **1**, **2**, **8** and **9** exhibited cytotoxic activity against P-388 cells with IC~50~ values of 5.7, 6.5, 10.3 and 13.8 µM, respectively. Compounds **1** and **2** also showed a moderate cytotoxic activity against SGC-7901 cells with IC~50~ values of 22.4 and 25.6 µM. Compounds **3**, **4**, **5**, **6** and **7** were inactive (IC~50~ \> 50 µM) against to the cell lines above.

molecules-19-03055-t002_Table 2

###### 

Cytotoxic activity of compounds **1**--**9** against four cancer cell lines *in vitro*.

  Compounds ^a^   Cytotoxic activity (IC~50~, µM)                 
  --------------- --------------------------------- ------ ------ ------
  **1**           5.7                               \>50   22.4   \>50
  **2**           6.5                               \>50   25.6   \>50
  **8**           10.3                              \>50   \>50   \>50
  **9**           13.8                              \>50   \>50   \>50
  Cisplatin ^b^   0.3                               0.9    3.2    1.1

P-388 = mouse lymphocytic leukemia cell line; A-549 = human lung carcinoma cell line; SGC-7901 = human gastric carcinoma cell line; HL-60 = human promyelocytic leukemia cell line; ^a^ Compounds **3**, **4**, **5**, **6** and **7** were inactive (IC~50~ \> 50 µM) against all cell lines; ^b^ Cisplatin was used as positive control.

3. Experimental
===============

3.1. General Information
------------------------

Optical rotations were measured with a Perkin-Elmer 343 polarimeter. 1D and 2D NMR spectra were recorded on a Bruker AVANCE-500 spectrometer with TMS as internal standard. ESIMS and HRESIMS were carried out on a Micromass Quattro mass spectrometer. HPLC was carried out on a Dionex P680 liquid chromatograph equipped with a UV 170 UV/Vis detector using a YMC-Pack R&D ODS A column (20 × 250 mm i.d., 5 μm, YMC Co., Ltd., Kyoto, Japan) and monitored at 225, 250, 275, 300 nm, simultaneously. Column chromatographies were performed on silica gel (200--300 mesh and 300--400 mesh; Qingdao Marine Chemical Inc., Qingdao, P. R. China), reversed phase silica gel (Lichroprep RP-18, 40--63 µm, Merck Inc., New York, NY, USA), and Sephadex LH-20 (40--70 µm, GE-Healthcare, Uppsala, Sweden). Chemical reagents for isolation were of analytical grade and purchased from Tianjin Fuyu Chemical Co. Ltd. (Tianjin, China).

3.2. Plant Material
-------------------

The stem bark of *Daphniphyllum macropodum* was collected in Chongqing Province, People's Republic of China, in November 2012, and identified by associate researcher Maoxiang Lin of the Chongqing Institute of Medicinal Plant Cultivation. A voucher specimen (XJ-T20121215) was deposited in the Herbarium of the Department of Pharmacy, Xijing Hospital, Fourth Military Medical University.

3.3. Extraction and Isolation
-----------------------------

The air-dried and powdered stem bark (20.0 kg) of *Daphniphyllum macropodum* was extracted three times with refluxing 95% EtOH (200 L, 2 h each time). After removal of the solvent under reduced pressure, the extract (2.1 kg) was dispersed in water and adjusted with 1% HCl to pH 2--3, then filtered. The aqueous phase was adjusted to pH 10 with 2 mol∙L^−1^ NaOH followed by extraction with CHCl~3~ to get the crude alkaloid (45.0 g). The crude alkaloid was subjected to a silica gel column eluting with a CHCl~3~/CH~3~OH (1:0 to 0:1) gradient to obtain four major fractions (A to D). Fraction A (15.5 g) was chromatographed on a silica gel column eluting with a CHCl~3~/CH~3~OH (20:1 to 10:1) gradient to give ten further fractions (A1--A10). Fraction A5 was subjected to size exclusion chromatography on a Sephadex LH-20 column equilibrated with CH~3~OH to remove the pigments and impurities, then was further purified by HPLC to afford compounds **1** (7.7 mg, *t*~R~ = 20.2 min), **2** (6.2 mg, *t*~R~ = 21.2 min) and **4** (5.5 mg, *t*~R~ = 33.6 min) eluting with MeOH/H~2~O (8:3) at a flow rate of 6 mL/min. Paxiphylline C (5.7 mg, *t*~R~ = 18.1 min) and compound **3** (4.4 mg, *t*~R~ = 24.5 min) were obtained from fraction A7 by HPLC eluting with MeOH/H~2~O (7:3) at a flow rate of 8 mL/min. Fraction A10 was purified by HPLC to give compound **5** (7.2 mg, *t*~R~ = 22.5 min) eluting with MeOH/H~2~O (6:4) at a flow rate of 6 mL/min. Fraction B (15.0 g) was subjected to silica gel column chromatography eluting with a CHCl~3~/CH~3~OH (10:1 to 0:1) gradient to afford two fractions (B1 and B2). Fraction B1 was purified over a Sephadex LH-20 column equilibrated with CH~3~OH to yield macropodumine C (15.8 mg). Fraction C (3.4 g) was chromatographed over a Sephadex LH-20 column equilibrated with CH~3~OH to remove the pigments and impurities, and finally purified by means of HPLC eluting with MeOH/H~2~O (4:6) to yield daphnicyclidin A (4.8 mg) in 27.5 min and macropodumine B (17.6 mg) in 37.6 min.

*Daphnicyclidin M* (**1**): amorphous light yellow powder; ![](molecules-19-03055-i001.jpg) −40.3 (*c* 0.11, MeOH); UV (MeOH) λ~max~ (log ε) 274 (1.36), 221 (1.26) nm; IR (KBr) *ν*~max~ 3423, 2915, 1690, 1643, 1616, 1522, 1454, 1375, 1127, 984 cm^−1^; ^1^H-NMR and ^13^C-NMR, see [Table 1](#molecules-19-03055-t001){ref-type="table"}; positive ESIMS *m/z* 418 \[M+Na\]^+^; positive HRESIMS \[M+Na\]^+^ *m/z* 418.1632 (calcd for C~23~H~25~NO~5~Na, 418.1630).

*Daphnicyclidin N* (**2**): amorphous light yellow powder; ![](molecules-19-03055-i001.jpg) −65.5 (*c* 0.11, MeOH); UV (MeOH) λ~max~ (log ε) 281 (1.14), 204 (5.00) nm; IR (KBr) *ν*~max~ 3425, 2920, 1686, 1643, 1616, 1525, 1456, 1385, 1126, 991 cm^−1^; ^1^H-NMR and ^13^C-NMR, see [Table 1](#molecules-19-03055-t001){ref-type="table"}; positive ESIMS *m/z* 448 \[M+Na\]^+^; positive HRESIMS \[M+Na\]^+^ *m/z* 448.1738 (calcd for C~24~H~27~NO~6~Na, 448.1736).

*Calyciphylline Q* (**3**): light yellow oil; ![](molecules-19-03055-i001.jpg) −16.8 (*c* 0.08, MeOH); UV (MeOH) λ~max~ (log ε) 280 (4.96) nm; IR (KBr) *ν*~max~ 2925, 1709, 1685, 1615, 1440, 1378, 1096 cm^−1^; ^1^H-NMR and ^13^C-NMR, see [Table 1](#molecules-19-03055-t001){ref-type="table"}; positive ESIMS *m/z* 388 \[M+Na\]^+^; positive HRESIMS \[M+Na\]^+^ *m/z* 388.1890 (calcd for C~23~H~27~NO~3~Na, 388.1889).

*Calyciphylline R* (**4**): light yellow oil; ![](molecules-19-03055-i001.jpg) −44.7 (*c* 0.15, MeOH); UV (MeOH) λ~max~ (log ε) 270.5 (4.23), 204.5 (4.88) nm; IR (KBr) *ν*~max~ 2920, 1745, 1695, 1575, 1445, 1380 cm^−1^; ^1^H-NMR and ^13^C-NMR, see [Table 1](#molecules-19-03055-t001){ref-type="table"}; positive ESIMS *m/z* 342 \[M+H\]^+^; positive HRESIMS \[M+H\]^+^ *m/z* 342.2068 (calcd for C~21~H~28~NO~3~, 342.2069).

*Calyciphylline S* (**5**): light yellow oil; ![](molecules-19-03055-i001.jpg) −81.2 (*c* 0.13, DMSO); UV (MeOH) λ~max~ (log ε) 247.5 (4.54) nm; IR (KBr) *ν*~max~ 3425, 2920, 1701, 1675, 1611, 1438, 1380, 1226, 995, 565 cm^−1^; ^1^H-NMR and ^13^C-NMR, see [Table 1](#molecules-19-03055-t001){ref-type="table"}; positive ESIMS *m/z* 360 \[M+H\]^+^; positive HRESIMS *m/z* \[M+H\]^+^ 360.2172 (calcd for C~21~H~30~NO~4~, 360.2175).

3.4. Assays for In Vitro Antitumor Activity
-------------------------------------------

The cytotoxicity of compounds **1**--**9** against mouse lymphocytic leukemia P-388 cells, human lung carcinoma A-549 cells, human promyelocytic leukemia HL-60 cells and human gastric carcinoma SGC-7901 cells was evaluated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) colorimetric assay method *in vitro*. All cells were cultured in RPMI-1640 medium supplemented with 10% fetal bovine serum, 100 U/mL benzyl penicillin, and 100 U/mL streptomycin at 37 C in a humidified atmosphere with 5% CO~2~. The logarithmic phase cells were seeded on 96-well plates at the concentration of 4 × 10^3^ cell/mL and incubated with various concentrations (100, 80, 60, 40, 20, 10, 1 and 0.25 μM in medium containing less than 0.1% DMSO) of test compounds in triples wells for 48 h, and cisplatin was used as positive control. After that, 20 μL MTT (5 mg/mL) was added to each well, and incubated for another 4 h. The water-insoluble dark blue formazan crystals formed during MTT cleavage in actively metabolizing cells were dissolved in DMSO. The optical density of each well was measured with a Bio-Rad 680 microplate reader at 570 nm. Cytotoxicity was expressed as the concentration of drug inhibiting cell growth by 50% (IC~50~).

4. Conclusions
==============

Phytochemical investigation of the stem bark of *Daphniphyllum macropodum*, lead to the isolation of five new *Daphniphyllum* alkaloids **1**--**5**, along with four known ones **6**--**9**. Their structures and relative configurations were elucidated on the basis of spectroscopic methods, especially 2D NMR techniques. All of the compounds were tested for cytotoxic activity against P-388, A-549, HL-60 and SGC-7901 cell lines. P-388 cells were sensitive to compounds **1**, **2**, **8** and **9**, which exhibited selective cytotoxic activity with IC~50~ values of 5.7, 6.5, 10.3 and 13.8 µM, respectively. Interestingly, compounds **1** and **2** also showed a moderate cytotoxic activity against SGC-7901 cells with IC~50~ values of 22.4 and 25.6 µM. These preliminary results suggested that the cytotoxicity of these compounds appeared to be structure dependent, indicating that *Daphniphyllum* alkaloids of the **1** and **2** structural type possessed the potential for further investigation.
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